Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637504 · ClinicalTrials.gov registry record · NA
Feasibility of a Mobile Medication Plan Application in CF Patient Care
A NA study of Cystic Fibrosis and Cystic Fibrosis in Children, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 5
- Study locations
NCT03637504: Completed NA study of Cystic Fibrosis and Cystic Fibrosis in Children, sponsored by Boston Children's Hospital.
NCT03637504 is a NA study of Cystic Fibrosis and Cystic Fibrosis in Children that has completed, run by Boston Children's Hospital. The registered enrollment target is 105 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (41% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03637504, a NA study of Cystic Fibrosis and Cystic Fibrosis in Children, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a pilot, multicenter, prospective, randomized controlled study to evaluate the feasibility of an innovative medication adherence intervention utilizing a web-based, mobile medication management application \[MedActionPlan® (MAP)\] to encourage self-management by reinforcing adherence and education about treatment regimens in Participants with cystic fibrosis (CF) (ages 12 years and older). Outcomes of interest for this study are 1) feasibility of MAP in real-world setting which will be evaluated using patient/caregiver and clinician feedback regarding value, ease of use, and challenges with use, 2) effect of MAP on patient/caregiver knowledge and perception of medication use, 3) effect of MAP on adherence to inhaled and oral medications used in chronic management of CF. Preliminary data regarding outcomes on exacerbations, lung function, and health care system utilization (e.g., emergency department visits, hospitalization) will also be examined as part of this study.
Primary Outcome
This measure was developed for this specific study to evaluate feasibility and acceptability of patient use through aspects of usability and quality (engagement, usefulness, functionality/ease of use, aesthetics, information, and satisfaction) of the web portal and application. Assessed by 5 point Likert Scale: Strongly disagree, Disagree, Neither Agree or Disagree, Agree, Strongly Agree
Conditions Studied
Interventions
- BEHAVIORAL MedActionPlan®
Study Locations (5)
Alabama
- Children's of Alabama - Birmingham
Arizona
- University of Arizona and Banner Health - Tucson
California
- Lucille Packard Children's Hospital Stanford - Stanford
Maryland
- Johns Hopkins University - Baltimore
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT03637504 record still lists
NCT03637504 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (41% lower).
The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which MedActionPlan® is the first listed.
NCT03637504 lists 5 locations in 5 states (Alabama, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT03637504 about?
NCT03637504 is a clinical study titled "Feasibility of a Mobile Medication Plan Application in CF Patient Care". This is a pilot, multicenter, prospective, randomized controlled study to evaluate the feasibility of an innovative medication adherence intervention utilizing a web-based, mobile medication management application \[MedActionPlan® (MAP)\] to encourage self-management by reinforcing adherence and edu...
What is the current status of trial NCT03637504?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2018-09-05. Estimated completion is 2021-06-30.
What conditions does trial NCT03637504 study?
This clinical trial studies the following conditions: Cystic Fibrosis, Cystic Fibrosis in Children.
What interventions are being tested in trial NCT03637504?
The interventions under investigation include: MedActionPlan® (BEHAVIORAL).
Who is sponsoring clinical trial NCT03637504?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03637504 being conducted?
This trial has 5 study locations across Alabama, Arizona, California, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03637504's enrollment target sits among peer trials
105 58th of 169 higher than 111 of 169 other Cystic Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cystic Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise in Child Health
RECRUITING · NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
FEED-Cystic Fibrosis (FEED-CF)
RECRUITING · NA
-
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
RECRUITING · NA
-
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
RECRUITING · NA
-
Lung Transplant READY CF 2: CARING CF Ancillary RCT
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI